MS prevalence has doubled since 2000, driven by better diagnostics and longer life expectancy. However, researchers warn of significant inequalities, with patients in deprived areas facing higher mortality and delayed care.
MS prevalence has doubled since 2000, driven by better diagnostics and longer life expectancy. However, researchers warn of significant inequalities, with patients in deprived areas facing higher mortality and delayed care.
Share this Article
Recommended